研究发现,在紧急护理中使用致幻剂与较高的双极紊乱风险相关联。 Hallucinogen use in emergency care linked to higher bipolar disorder risk, study finds.

一项发表于2025年12月2日的加拿大研究发现,因使用幻觉药物 (如胺,LSD或青) 住院或在急诊室接受治疗的人,在其他原因住院的人相比,在三年内接受躁狂治疗的可能性是6倍,患双相情感障碍的可能性是4倍. A Canadian study published December 2, 2025, finds people hospitalized or treated in emergency departments for hallucinogen use—like ketamine, LSD, or psilocybin—were six times more likely to receive mania treatment and four times more likely to be diagnosed with bipolar disorder within three years compared to those hospitalized for other reasons. 这项研究分析了2008年至2022年的85 000多份患者记录,指出大多数个人以前有心理健康或吸毒问题。 The research analyzed over 85,000 patient records from 2008 to 2022, noting most individuals had prior mental health or substance use issues. 虽然研究结果表明急性致幻剂使用与未来情绪紊乱之间有联系,但研究人员提醒注意,结果主要适用于那些寻求紧急护理的人,可能不反映更广泛的使用者。 While the findings suggest a link between acute hallucinogen use and future mood disorders, researchers caution the results apply mainly to those seeking urgent care and may not reflect broader user populations. 他们强调,需要进一步研究以了解风险,特别是在探索用于治疗用途的致幻剂时。 They stress the need for further study to understand risks, especially as hallucinogens are explored for therapeutic use.